- Professor of Clinical Neurosurgery, School of Medicine, State University of New York at Stony Brook, New York, and Chief of Neurosurgical Spine and Education, NYU Winthrop Hospital, NYU Winthrop NeuroScience/Neurosurgery, Mineola, New York 11501, USA
DOI:10.25259/SNI-57-2019Copyright: © 2019 Surgical Neurology International This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
How to cite this article: Nancy E. Epstein. Avoiding inappropriate spine surgery in a patient with major cardiac comorbidities. 26-Mar-2019;10:44
How to cite this URL: Nancy E. Epstein. Avoiding inappropriate spine surgery in a patient with major cardiac comorbidities. 26-Mar-2019;10:44. Available from: http://surgicalneurologyint.com/surgicalint-articles/9240/
Background: We as spine surgeons increasingly need to carefully screen our own patients for major medical/cardiac comorbidities to determine if they are candidates for spine surgery. Our medical/cardiac colleagues rarely understand how long anti-platelet aggregates and non-steroidal anti-inflammatories (NSAIDs) have to be stopped prior to spine operaeitons, and when it is safe for them to be reinstated.
Case Study: A patient over 65 years of age, presented with 6 months of increased bilateral lower extremity sciatica, and 2-block neurogenic claudication. The MR scan showed moderate to severe lumbar stenosis L2-S1 with grade I L4-L5 spondylolisthesis, and multiple bilateral synovial cysts. Nevertheless, his neurological examination was normal. Further, he had > 5 stents placed within the last five years, and had undergone cardiac surgery two years ago requiring placement of a bovine aortic valve, and resection of a left ventricular wall aneurysm. He was also still on full dose Aspirin (325 mg/day), and Clopidogrel (75 mg po bid). Notably, 3 prior spinal surgeons (neurosurgery/orthopedics) had recommended multilevel lumbar laminectomy with instrumented fusions (e.g. including multilevel transforaminal lumbar interbody fusions (TLIF)).
Conclusions: Despite multilevel L2-S1 stenosis, Grade I L4-L5 spondylolisthesis, and multilevel bilateral synovial cysts, the patient’s normal neurological examination and multiple cardiac comorbidities (i.e. requiring continued full-dose ASA/Clopidogrel) precluded, in my opinion, offering surgical intervention. Rather, I referred the patient to neurology for conservative management. What would you have done?
Keywords: Multiple Cardiac Stents: Valve Replacement, Cardiac Myomectomy, Hypertrophic Cardiomyopathy, Clopidogrel, Aspirin Therapy, Anticoagulation
As spine surgeons, we have to increasingly determine whether a patient with multiple medical/cardiac comorbidities can “safely” undergo spine surgery. Although our medical/cardiac colleagues may “clear a patient” for such procedures, they rarely understand when and how long anti-platelet aggregates and non-steroidal anti-inflammatory (NSAID) therapies should be stopped perioperatively to avoid bleeding complications.
Here, a male over 65 years of age, presented with bilateral lumbar radiculopathy, and 2-block neurogenic claudication. MR/CT and dynamic X-ray studies documented L2-S1 severe lumbar stenosis, grade I L45 degenerative spondylolisthesis, and multilvel bilateral synovial cysts. However, his neurological examination was normal, and he had > 5 cardiac stents placed within the last five years. Additionallliy, 2 years ago he had an aortic porcine valve replacement with left ventricular mymectomy. Further, for continued cardiovascular prophylaxisresult, he remained on full dose Aspirin (325 mg/day), and Clopidogrel (75 mg po bid) therapy. Should this patient be a candidate for lumbar spine surgery with/without instrumentation?
Clinical History and Lumbar MR Findings
A male over 65 years of age presented with a 6-month history of mild/moderate bilateral lower extremity sciatica and 2-block neurogenic claudication. The MR, CT, and dynamic X-ray studies documented moderate/severe L2-S1 lumbar stenosis with Grade I L4-L5 spondylolisthesis, and multilevel bilateral synovial cysts. Notably, his neurological examination was normal.
The patient had > 5 cardiac stents placed within the last 5 years. Additionally, 2 years ago, he underwent a bovine aortic valve replacement with left-ventricular myomectomy for hypertrophic cardiomyopathy/aneurysmal dilatation. He was still on both Aspirin 325 mg/day, and Clopidogrel 75 mg po bid.
3 Other Spine Surgeons Recommended Instrumented L2-S1 Fusions
Three other spine surgeons (neurosurgeons/orthopedists) recommended multilevel L2-S1 decompressions with instrumented fusions (e.g. including multilevel transforaminal lumbar interbody fusions (TLIF)). None clearly discussed the potential risks of multilevel TLIF (e.g. risk of instrument-related failures attributed to osteopenia/osteoporosis given his long-term use of anti-platelet therapy), or the cardiovascular risks of acutely stopping ASA and Clopidogrel (e.g. major life-threatending thrombotic/embolic events).
My Surgical Recommendations
If the Patient Had No Significant Cardiac Comorbidities
If this patient had no significant cardiac comorbidities, and had failed a full trial of conservative management, he would have become a candidate for a decompressive laminectomy alone, or laminectomy with non-instrumented (in situ) posterolateral L4-L5 fusion.
With Cardiac Comorbidities as In This Case
The patient was neurologically intact. He had a history of >5 cardiac stents over the last 5 years. Additionally, 2 years ago, he had undergone cardiac surgery including placement of a porcine aortic valve plus myomectomy for ventricular aneurysmal dilatation. He was still on both Aspirin and Clopidogrel. I would, therefore, not have recommended spinal surgery for this patient who I considered to be at increased risk for thrombotic/embolic cardiovascular events should anti-platelet therapy be abruptly discontinued. Additionally, I would not have offered an instrumented fusion, as he was likely severely osteopenic or frankly osteoporotic given his chronic long-term use of ASA. What would you, as a spine surgeon, have done?
Brief Summary of When to Stop Anti-Platelet and Non-Steroidal Anti-Inflammatory Medications (NSAIDs) Prior to Spine Surgery
Anti-platelet aggregates (e.g. Aspirin (ASA), Clopidogrel (Plavix)) should typically be stopped at > 7-10 days prior to spine surgery.[1-5] Kang et al. (2011) documented that low-dose ASA resulted in greater perioperative blood loss for patients (mean age 68.5) undergoing 2-level spinal surgery, and agreed to stopping low dose ASA 7 days preoperatively.[
Specific Times to Stop Different NSAIDs Prior to Spine Surgery
In 2014, Park et al. compared estimated blood loss for ASA with/without NSAIDs in lumbar fusion patients. They found the failure to stop ASA and NSAIDs for adequate periods of time preoperatively significantly increased perioperative bleeding risks in all groups (i.e. even if ASA was stopped 1 week preoperatively with varying intervals for the different NSAIDs).[
Despite the L2-S1 moderate/severe spinal stenosis, Grade I L4-L5 spondylolisthesis, and bilateral multiple synovial cysts, the patient’s normal neurological examination and his major cardiovascular comorbidities made him a poor candidate, in my opinion, for lumbar surgery. Three other spine surgeons offered him multilevel instrumented fusions and failed, in my opinion, to recognize the significant comorbid risk factors that, more likely than not, would have contributed to significant perioperative morbidity/mortality.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
1. Gerstein NS, Schulman PM, Gerstein WH, Petersen TR, Tawil I. Should more patients continue aspirin therapy perioperatively? clinical impact of aspirin withdrawal syndrome. Ann Surg. 2012. 255: 5-
2. Kang SB, Cho KJ, Moon KH, Jung JH, Jung SJ. Does low-dose aspirin increase blood loss after spinal fusion surgery?. Spine J. 2011. 11: 303-7
3. Narouze S, Benzon HT, Provenzano D, Buvanendran A, De Andres J, Deer T. Interventional Spine and Pain Procedures in Patients on Antiplatelet and Anticoagulant Medications (Second Edition): Guidelines From the American Society of Regional Anesthesia and Pain Medicine, the European Society of Regional Anaesthesia and Pain Therapy, the American Academy of Pain Medicine, the International Neuromodulation Society, the North American Neuromodulation Society, and the World Institute of Pain. Reg Anesth Pain Med. 2018. 43: 225-262
4. Park JH, Ahn Y, Choi BS, Choi KT, Lee K, Kim SH. Antithrombotic effects of aspirin on 1- or 2-level lumbar spinal fusion surgery: a comparison between 2 groups discontinuing aspirin use before and after 7 days prior to surgery. Spine (Phila Pa 1976). 2013. 38: 1561-5
5. Park HJ, Kwon KY, Woo JH. Comparison of blood loss according to use of aspirin in lumbar fusion patients. Eur Spine J. 2014. 23: 1777-82